__NUXT_JSONP__("/drugs/Prinomastat", (function(a,b){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"192329-42-3",chebiId:"",chemicalFormula:"C18H21N3O5S2",definition:"A synthetic hydroxamic acid derivative with potential antineoplastic activity.  Prinomastat inhibits matrix metalloproteinases (MMPs) (specifically, MMP-2, 9, 13, and 14), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis.  As a lipophilic agent, prinomastat crosses the blood-brain barrier.",fdaUniiCode:"10T6626FRK",identifier:"C1811",preferredName:a,semanticType:"Organic Chemical",subclassOf:["C1970"],synonyms:["(3S)-N-Hydroxy-2,2-dimethyl-4-{{4-(4-piridinyloxy)phenyl}sulfonyl}-3-thiomorpholinecarboxamide","AG3340","PRINOMASTAT",a,"prinomastat"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FPrinomastat",extension:".json",createdAt:b,updatedAt:b}}],fetch:{},mutations:void 0}}("Prinomastat","2021-10-30T13:36:44.863Z")));